Discover key insights from Venus Concept Inc.'s Q3 2025 earnings call: EBD growth, Venus NOVA launch, and strategic challenges.

Q3 2025 Earnings Call November 13, 2025 8:00 AM ESTCompany ParticipantsRajiv Kanishka De Silva - CEO & DirectorDomenic Penna ...

TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three ...

FANCY popping to the other side of the world in just a few hours? It might not be as farfetched as it sounds. Aerospace ...

(2500.HK) today announced that Cardiovalve has submitted the CE technical file for its transcatheter tricuspid valve ...

Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three ...

NASA is facing increasingly sharp challenges as it pursues its goal of landing astronauts on the moon again before this ...

Celebrated astrologer Vikkramm Chandirramani shares an in-depth insight into Hrithik Roshan’s life and career and predicts what lies ahead.

Venus Medtech’s Cardiovalve subsidiary today announced the submission of its heart valve replacement system for CE Mark.

On November 18, 2025, ten companies, including Ashok Leyland and Asian Paints, turn ex-dividend. Investors must hold shares ...

Venus Concept (($VERO)) has held its Q3 earnings call. Read on for the main highlights of the call. Venus Concept’s latest earnings call presented ...

In Dissent is a recurring series by Anastasia Boden on Supreme Court dissents that have shaped (or reshaped) our country. I.